SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-23-000388
Filing Date
2023-12-08
Accepted
2023-12-08 16:03:53
Documents
1
Period of Report
2023-12-06

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3801
  Complete submission text file 0001610717-23-000388.txt   5193
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Issuer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
Morrison Scott W (Reporting) CIK: 0001662426 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37719 | Film No.: 231475354